K
Kimon Stamatelopoulos
Researcher at National and Kapodistrian University of Athens
Publications - 251
Citations - 6993
Kimon Stamatelopoulos is an academic researcher from National and Kapodistrian University of Athens. The author has contributed to research in topics: Blood pressure & Medicine. The author has an hindex of 39, co-authored 206 publications receiving 5470 citations. Previous affiliations of Kimon Stamatelopoulos include Alexandra Hospital & Newcastle University.
Papers
More filters
Journal ArticleDOI
Acute and long-term hemodynamic effects of sesame oil consumption in hypertensive men.
Kalliopi Karatzi,Kimon Stamatelopoulos,M. Lykka,Pigi Mantzouratou,Sofia Skalidi,Efstathios Manios,George Georgiopoulos,Nikolaos Zakopoulos,Christos Papamichael,Labros S. Sidossis,Labros S. Sidossis +10 more
TL;DR: This poster presents a probabilistic procedure to assess the importance of baseline IgE levels in the decision-making process and suggests that these levels are higher in women than in men.
Journal ArticleDOI
Oral folic acid enhances endothelial function in patients with hypercholesterolaemia receiving statins.
John Lekakis,Christos Papamichael,Theodoros G. Papaioannou,Anna G. Dagre,Kimon Stamatelopoulos,Dimitrios J. Tryfonopoulos,Athanassios D. Protogerou,Stamatios F. Stamatelopoulos,Myron Mavrikakis +8 more
TL;DR: Oral administration of folic acid (5 mg) for 4 weeks improves endothelial function in patients with hypercholesterolemia treated with statins, with possible beneficial effects on the prognosis of these patients.
Journal ArticleDOI
Amyloid-Beta (1-40) Peptide and Subclinical Cardiovascular Disease.
Kimon Stamatelopoulos,Christine J. Pol,Colby Ayers,Georgios Georgiopoulos,Aikaterini Gatsiou,Emmanouil S. Brilakis,Amit Khera,Konstantinos Drosatos,James A. de Lemos,Konstantinos Stellos +9 more
TL;DR: Amyloid-beta (1-40) (Aβ40), a peptide with proinflammatory and proatherosclerotic properties, is associated with arterial aging and with major adverse cardiovascular events in patients with stable coronary heart disease, heart failure, or acute coronary syndrome.
Journal ArticleDOI
The relationship between blood pressure and risk of atrial fibrillation: a Mendelian randomization study.
Georgios Georgiopoulos,Georgios Georgiopoulos,Georgios Ntritsos,Kimon Stamatelopoulos,Costas Tsioufis,Alberto Aimo,Stefano Masi,Stefano Masi,Stefano Masi,Evangelos Evangelou +9 more
TL;DR: In this article, Mendelian randomization (MR) was used to investigate the potential causal association of BP levels with the risk of developing incident atrial fibrillation (AF), but whether this relationship is causal remains unknown.
Journal ArticleDOI
Soluble lectin-like oxidized low-density lipoprotein receptor-1 predicts premature death in acute coronary syndromes.
Simon Kraler,Florian A. Wenzl,Georgios Georgiopoulos,Slayman Obeid,Luca Liberale,Arnold von Eckardstein,Olivier Muller,François Mach,Lorenz Räber,Sylvain Losdat,Martin Schmiady,Konstantinos Stellos,Kimon Stamatelopoulos,Giovanni G. Camici,Annie Srdic,Francesco Lanni,Alexander Akhmedov,Thomas F. Lüscher +17 more
TL;DR: Plasma sLOX-1 levels are increased during ACS and predict fatal events beyond traditional and emerging risk factors and Persistently high sLOx-1 associates with coronary plaque progression in patients with established ASCVD.